reports
- GlobalData Healthcare Department
AnaptysBio Inc (ANAB) - Financial Analysis Review
AnaptysBio Inc (ANAB) - Financial Analysis Review Summary AnaptysBio Inc (AnaptysBio) is a biotechnology company that develops antibody drug candidates. The company’s product pipeline comprises ANB020 and ANB019. It’s ANB020 is a product candidate used for the treatment of severe adult asthma and severe adult peanut allergy and ANB019 is a product candidate used for the treatment of rare inflammatory diseases such as generalized pustular psoriasis and palmoplantar pustular psoriasis. Glob...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.